ANI 制药 ANIP
$67.41 −$2.21 (-3.17%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $67.41 0.00%
开盘$69.05
昨收$69.62
当日区间$67.14 – $70.95
成交量578.2K
市值$1.53B
市盈率（TTM）13.4
股息率–
ANIP 相关新闻
匹配 ANI Pharmaceuticals 或代码 ANIP 的头条新闻，按最新排序。
- Leerink Partners Initiates ANI Pharmaceuticals(ANIP.US) With Buy Rating, Announces Target Price $104
- H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $121
- Barclays Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $100
- J.P. Morgan Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $115
- Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Cuts Target Price to $119 负面
- CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Cuts Target Price to $90 负面
- CCORF Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating, Maintains Target Price $91
- CCORF Downgrades ANI Pharmaceuticals(ANIP.US) to Hold Rating, Raises Target Price to $91 中性
- Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $124
- Truist Financial Maintains ANI Pharmaceuticals(ANIP.US) With Hold Rating
- Piper Sandler Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $111 正面
- Jefferies Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $120 正面
- Guggenheim Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $119
- J.P. Morgan Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP)
- J.P. Morgan Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $115
暂无评论——快来第一个聊聊 ANIP。
登录后参与讨论。